In this article we take a look at 10 best long-term dividend stocks to buy and hold. You can skip our detailed analysis of the performance of dividend...
Keep Reading →
February 24 - Hedge Funds, News - Comments
In this article we discuss the 5 Best Long-Term Dividend Stocks to Buy and Hold. If you want to read our detailed analysis of the dividend investing strategy...
Keep Reading →
February 24 - Hedge Funds, News - Comments
Below we present the list of Top 5 Large-Cap Healthcare Stocks to Buy Now. For our methodology and a more comprehensive look at Henrik Rhenman’s Rhenman...
Keep Reading →
February 6 - Hedge Fund Analysis, Hedge Funds, News - Comments
AbbVie Inc. (NYSE:ABBV) came into existence in 2013 after getting separated from parent Abbott Laboratories. The company has performed well since going...
Keep Reading →
February 5 - Earnings Report, News - Comments
In this article we discuss quant billionaire David Siegel’s top 10 stock picks. If you want to skip our discussion about Siegel’s investment...
Keep Reading →
February 2 - Hedge Funds, News - Comments
In this article we presented the top 10 dividend stocks Warren Buffett likes the most. Click to skip ahead and see the top 5 dividend stocks Warren Buffett...
Keep Reading →
December 9 - Dividend Stocks, Hedge Fund Analysis, News - Comments
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many...
Keep Reading →
November 30 - Hedge Funds, News - Comments
In this article we’ll check out the Top 5 Stocks Warren Buffett Just Bought. For more background on the Oracle of Omaha and some of his other top stock...
Keep Reading →
November 27 - Hedge Fund Analysis, Hedge Funds, News - Comments
Introduction As Mr. Valuation, I find myself constantly reminding investors that value investing requires patience. However, value investing also requires...
Keep Reading →
November 10 - Business, Dividend Stocks, Stock Analysis - Comments
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed...
Keep Reading →
October 20 - Hedge Funds, News - Comments
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Keep Reading →
August 26 - Hedge Funds, News - Comments
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the...
Keep Reading →
July 2 - Hedge Funds, News - Comments
Operation Warp Speed: The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates...
Keep Reading →
May 31 - Stock Analysis - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Keep Reading →
May 26 - Hedge Funds, News - Comments
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
Keep Reading →
April 22 - Hedge Funds, News - Comments
Activist Investor Makes New Push for HC2 Board to Remove Chief Falcone: Letter (Reuters) BOSTON (Reuters) – An activist investor is stepping up...
Keep Reading →
March 30 - Hedge Funds, Insider Trading - Comments
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. We estimate that COVID-19 will kill around 5 million people...
Keep Reading →
March 7 - Hedge Funds, News - Comments
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged in 2019. Among them, Facebook and Microsoft ranked...
Keep Reading →
December 29 - Hedge Funds, News - Comments
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook...
Keep Reading →
November 30 - Hedge Funds, News - Comments
We can judge whether AbbVie Inc (NYSE:ABBV) is a good investment right now by following the lead of some of the best investors in the world and piggybacking...
Keep Reading →
October 8 - Hedge Funds, News - Comments
Oil Tycoon T. Boone Pickens Left Behind an Incredible Letter About the Best Life Lessons He Learned, and Every Line is a Must-read (Business Insider)...
Keep Reading →
September 20 - Hedge Funds, Insider Trading - Comments
“The end to the U.S. Government shutdown, reports of progress on China-U.S. trade talks, and the Federal Reserve’s confirmation that it did not...
Keep Reading →
June 6 - Hedge Funds, News - Comments
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter. Among them, Amazon...
Keep Reading →
March 26 - Hedge Funds, News - Comments
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief...
Keep Reading →
December 8 - Hedge Funds, News - Comments
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher...
Keep Reading →
December 7 - Dividend Stocks, Hedge Funds, News - Comments
George Soros Bought These 2 Healthcare Stocks in the Third Quarter (The Motley Fool) Although billionaire superinvestor George Soros may no longer be...
Keep Reading →
December 3 - Hedge Funds, Insider Trading - Comments
Omeros Corporation (NASDAQ:OMER) (MarketWatch) Omeros Corp. OMER, +36.60% shares surged 45% in extremely heavy morning trade Thursday on a new government...
Keep Reading →
March 22 - Market Movers, News - Comments
Elliott Buys Tiny Stake in Wipro in First India IT Firm Holding (Bloomberg) Billionaire Paul Singer’s Elliott Management Corp. has bought a stake in...
Keep Reading →
March 12 - Hedge Funds, Insider Trading - Comments
There is no doubt that the marijuana industry in the US has a lot of growth potential. The sale of medical and recreational weed is expected to reach $...
Keep Reading →
February 22 - Commodities, Hedge Funds, News - Comments
Devon Energy Corp (NYSE:DVN) (MarketWatch) Shares of Devon Energy Corp. DVN, -10.16% fell 6% in premarket trading Wednesday, after the company posted...
Keep Reading →
February 21 - Market Movers, News - Comments
In this article we are going to present an alternative to weed stocks such as GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Cara Therapeutics Inc (NASDAQ...
Keep Reading →
February 2 - Commodities, Hedge Funds, News - Comments
AbbVie Inc (NYSE:ABBV) (CNBC) AbbVie, the maker of the world’s best selling drug, reported fourth-quarter profit on Friday that beat Wall Street...
Keep Reading →
January 26 - Market Movers, News - Comments
Marijuana industry in the US is still in its inception phase, but it’s growing, and the projections are very optimistic. This year, retail sales of...
Keep Reading →
December 11 - Commodities, Hedge Funds, News - Comments
Canada is undoubtedly one of the greatest countries on earth. They’ve got universal healthcare, beautiful scenery, a whole region that speaks French...
Keep Reading →
December 5 - Commodities, IPOs, News - Comments
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest...
Keep Reading →
November 24 - News - Comments
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and...
Keep Reading →
November 23 - News - Comments
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in. These...
Keep Reading →
July 17 - Dividend Stocks, News - Comments
If you’re seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the...
Keep Reading →
July 6 - News - Comments
You probably haven’t heard of Alex Denner‘s Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which...
Keep Reading →
May 16 - Hedge Fund Analysis, Hedge Funds, News - Comments
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators. Technology paints...
Keep Reading →
April 5 - Lists, News - Comments
Two patents that AbbVie Inc (NYSE:ABBV) held on Humira, a treatment for arthritis, have been invalidated by an English court. The ruling was in favor...
Keep Reading →
March 6 - News, Stock Analysis - Comments
The AbbVie Inc (NYSE:ABBV) board of directors has given the authorization required to increase $5 billion to the company’s existing share buyback program...
Keep Reading →
February 21 - News, Stock Analysis - Comments
The National Institute for Health and Care Excellence has refused to authorize AbbVie Inc (NYSE:ABBV)‘s Venclyxto on NHS. Besides the price, the...
Keep Reading →
February 16 - News, Stock Analysis - Comments
AbbVie Inc (NYSE:ABBV) just announced that it has picked up approval for one of its lead development candidates, but the company has failed to really...
Keep Reading →
January 20 - News, Stock Analysis - Comments
Yes, you read the title right there are at least 12 health benefits of medical marijuana according to publicly traded weed companies. Just keep on reading...
Keep Reading →
January 12 - Lists, News - Comments
AbbVie Inc (NYSE:ABBV) has sought a joint venture with its target discovery portfolio company, Emergent Technologies Inc, Pure MHC. The collaboration...
Keep Reading →
January 10 - News, Stock Analysis - Comments
A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations. The bill seeks to shed...
Keep Reading →
January 3 - News, Stock Analysis - Comments
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros. Ranked 128th on Forbes’ list of the richest people...
Keep Reading →
December 23 - Dividend Stocks, Hedge Funds, News - Comments
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration...
Keep Reading →
December 21 - News, Stock Analysis - Comments
Larry Robbins’ Glenview Capital Management reported an equity portfolio worth over $13.98 billion in its latest 13F filing. The fund has a heavy...
Keep Reading →
December 16 - Hedge Funds, News - Comments